gptkbp:instance_of
|
gptkb:disease
|
gptkbp:available_on
|
gptkb:pharmaceuticals
|
gptkbp:brand
|
gptkb:Dulcolax
Dulcolax Liquid
Dulcolax Stool Softener
Dulcolax Suppositories
|
gptkbp:category
|
Category B
|
gptkbp:clinical_use
|
bowel preparation before surgery
preparation for diagnostic procedures
short-term treatment of constipation
|
gptkbp:contraindication
|
gptkb:Crohn's_disease
gptkb:ulcerative_colitis
severe dehydration
appendicitis
intestinal obstruction
|
gptkbp:dosage_form
|
oral tablet
rectal suppository
10 mg rectally
5 to 15 mg orally
|
gptkbp:financial_support
|
consult a doctor if symptoms persist
do not exceed recommended dosage
|
gptkbp:form
|
gptkb:tablet
suppository
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dulcolax
|
gptkbp:ingredients
|
bisacodyl
|
gptkbp:interacts_with
|
antacids
diuretics
other laxatives
|
gptkbp:manufacturer
|
gptkb:Boehringer_Ingelheim
|
gptkbp:premiered_on
|
15 to 60 minutes rectally
6 to 12 hours orally
|
gptkbp:release_region
|
gptkb:Australia
gptkb:Canada
gptkb:Germany
gptkb:United_Kingdom
gptkb:United_States
|
gptkbp:route_of_administration
|
oral
rectal
|
gptkbp:side_effect
|
dizziness
nausea
diarrhea
abdominal cramping
|
gptkbp:storage
|
room temperature
away from moisture
|
gptkbp:used_for
|
constipation
|
gptkbp:bfsParent
|
gptkb:Pfizer_Consumer_Healthcare
|
gptkbp:bfsLayer
|
5
|